Latest 8-K filings

NYSE
Global Partners LP announced robust second-quarter 2026 financial results, showcasing substantial increases in net income, EBITDA, and distributable cash flow compared to the prior year.
NASDAQ
Jerash Holdings (US), Inc. announced its board of directors has approved a regular quarterly dividend of $0.05 per share.
OID
Earth Science Tech, Inc. announced robust fiscal first quarter 2027 results, marked by a 57% surge in net income and a 108% increase in operating cash flow.
NASDAQ
Calumet, Inc. reported a second quarter 2026 net loss of $95.9 million, impacted by non-cash RINs and mark-to-market items, though Adjusted EBITDA with Tax Attributes reached $175.2 million.
NASDAQ
Construction Partners, Inc. announced robust fiscal 2026 third quarter results, featuring a 28% revenue increase and a 24% rise in Adjusted EBITDA, alongside a record backlog and an improved full-year financial forecast.
NASDAQ
Allegro MicroSystems, Inc. held its Annual Meeting of Shareholders on August 5, 2026, where shareholders elected directors, ratified the appointment of PricewaterhouseCoopers, LLP, and approved executive compensation.
NASDAQ
Mammoth Energy Services announced a significant 110% year-over-year revenue increase to $26.1 million and a 37% sequential rise in Adjusted EBITDA to $2.6 million for Q2 2026, prompting an upward revision of its full-year outlook.
NYSE
Royal Caribbean Cruises Ltd. has entered into an underwriting agreement to issue and sell $1.25 billion in aggregate principal amount of 5.550% Senior Notes due 2034.
Dauch Corporation announced robust second quarter 2026 financial results, driven by its recent acquisition, with significant increases in sales and operating cash flow, alongside an improved full-year financial outlook.
NASDAQ
Gyre Therapeutics announced its second quarter 2026 financial results, reporting $29.1 million in revenue and affirming full-year revenue guidance, while also detailing progress on its pipeline and the acquisition of Cullgen.
NYSE
PPL Corporation announced strong second-quarter 2026 financial results, exceeding prior year earnings and reaffirming its full-year guidance and long-term growth targets.
NASDAQ
Wheeler Real Estate Investment Trust adjusts convertible note conversion price significantly downward following preferred stock redemptions, leading to substantial common stock issuance.
NASDAQ
DENTSPLY SIRONA Inc. filed an amendment to its Form 8-K to correct an EDGAR description tag, confirming its second quarter 2026 financial results and reiterating its full-year outlook.
NASDAQ
Take-Two Interactive reported Q1 FY27 results with net bookings slightly above guidance, driven by strong recurrent consumer spending, and reiterated its full-year outlook, anticipating the Grand Theft Auto VI launch.
NASDAQ
ACM Research announced robust second quarter 2026 financial results, with revenue and shipments up 36% year-over-year, and raised its full-year revenue outlook to 25%-30% growth.
NYSE
Alpha Metallurgical Resources presented its investor overview for August 2026, detailing operational performance, market outlook, and financial summary, including guidance for the remainder of 2026.
NYSE
Telephone and Data Systems, Inc. announced its second quarter 2026 results, highlighting growth in TDS Telecom's fiber footprint and Array's site rental revenue, alongside updated financial guidance for both segments.
Array Digital Infrastructure announced robust second quarter 2026 results, featuring a 90% surge in total operating revenues and a significant increase in net income, alongside updated positive financial guidance for the full year.
NYSE
Alpha Metallurgical Resources announced a net loss of $12.3 million for the second quarter of 2026, with Adjusted EBITDA falling to $25.6 million, impacted by lower shipment volumes and higher costs.
NYSE
Under Armour reported a 3% revenue decrease for Q1 FY27, driven by North America, while maintaining its full-year profitability outlook despite updating revenue expectations.
NASDAQ
The E.W. Scripps Company reported a $1.2 billion net loss for Q2 2026, driven by a $1.1 billion goodwill impairment charge, while revenue declined 9.2% year-over-year.
NYSE
Kimbell Royalty Partners LP announced record-breaking second quarter 2026 results, including record revenues, net income, Adjusted EBITDA, and production, alongside a 15% increase in cash distribution.
NYSE
Douglas Elliman reported a 4.5% year-over-year revenue increase in Q2 2026, with operating and net losses narrowing, driven by strategic growth initiatives including AI transformation and market expansion.
NYSE
Sylvamo announced a second quarter net loss of $11 million, with adjusted EBITDA of $60 million, as it navigates strategic investments, supply chain adjustments, and external market pressures.
NASDAQ
Minerva Neurosciences reported second quarter 2026 financial results and business updates, highlighting ongoing Phase 3 trial progress for roluperidone while financial performance was significantly impacted by non-cash warrant liability adjustments.
NASDAQ
Treace Medical Concepts, Inc. reported second quarter 2026 revenue of $45.4 million, a 4% decrease year-over-year, alongside a net loss of $15.9 million, though the company raised its full-year Adjusted EBITDA guidance.
NASDAQ
Embecta Corp. reported third quarter fiscal year 2026 financial results, showing a year-over-year revenue decrease of 8.1% to $271.7 million, though sequential revenue improved by $50 million.
NASDAQ
Wendy's announced second-quarter 2026 results showing a decline in global systemwide sales and net income, leading to a withdrawal of its 2026 outlook and a reduction in its quarterly dividend.
NASDAQ
Canopy Growth announced its first quarter fiscal year 2027 financial results, reporting a 13% increase in consolidated net revenue to $81.2 million and a 59% reduction in Adjusted EBITDA loss.
NASDAQ
Kiora Pharmaceuticals announced its second quarter 2026 financial results, highlighting progress in its Phase 2 trials for KIO-301 and KIO-104, and an extended operational runway into late 2028.